glp-1 drug supply news today FDA says that the shortage is over GLP-1 Drug Shortages and Compounding

Longer studies (1 year) showed 43.8% fewer flare-ups and improved lung flow by nearly 97% (NIH)

Overall, GLP-1 receptor agonists appear most beneficial for cardiometabolic risk reduction, obesity management, and prevention of atherosclerotic cardiovascular events

No adjustments in immunosuppressant therapy were reported

Perfect for quick formulations, ready-to-use bases, or adding a performance boost to existing products

doi: 10.3390/nu11092073 26

The four SCLAs were also senolytic against a wide range of senescent cells, including IMR90 cells treated with etoposide, MCF7 breast cancer cells treated with either etoposide or tozasertib and PC3 prostate cancer cells treated with palbociclib (Extended Data Fig